Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2004
Primary objective: To evaluate the efficacy of two different dosing schedules of MS-275 in subjects with metastatic melanoma Secondary objectives: To evaluate the safety and to assess the pharmacokinetic profile of MS-275 in subjects with metastatic melanoma
Epistemonikos ID: 9deb760d22d82870f376958b58dac902de2eedcc
First added on: May 04, 2024